Xinhong Wu
National Key Clinical Specialty Construction Discipline, No. 116 ZhuoDaoquan South Road
Wuhan, 430079, China
Wuhan, 430079, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: March 19, 2026
Clinicopathological characteristics and prognosis of breast carcinoma with apocrine differentiation: a propensity score-matched analysis of the SEER database.
Journal: Translational cancer research
Published: March 18, 2026
Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial.
Journal: BMJ (Clinical research ed.)
Published: March 16, 2026
Research Progress of PROTACs in Breast Cancer: Subtype-Oriented Target Landscape, Clinical Stratification Evidence, and Engineering Strategies for Translation.
Journal: Biomedicines
Published: March 01, 2026
25HC regulates the polarization of CD163+ macrophages in the immune microenvironment of triple-negative breast cancer through the interferon pathway.
Journal: Frontiers in immunology
Published: February 16, 2026
Cyclin-Dependent Kinases 4 and 6 Inhibitors: An Emerging Therapeutic Framework from Growth Suppression to Tumor Clearance.
Journal: ACS pharmacology & translational science
Published: January 03, 2026
Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study.
Journal: Breast (Edinburgh, Scotland)
Published: November 28, 2025
Breast Cancer Therapy with Quantum Dots: NIR-II Image-Guided Interventions, Multimodal Treatment, and Translation.
Journal: Current medicinal chemistry
Published: November 23, 2025
Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study.
Journal: Breast cancer (Dove Medical Press)
Published: November 06, 2025
Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer.
Journal: Signal transduction and targeted therapy
Published: September 14, 2025
OVH-guided planning for superior heart and lung sparing in breast cancer radiotherapy.
Journal: Journal of applied clinical medical physics
Published: September 14, 2025
Last Updated: 09/26/2026